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Previously to this paper we had given an account on our synthetic pharmacological investi-
gations carried out mainly on the field of N-tertiary aminoesters, thio ethers, unsaturated and 
saturated aminopropene derivaties. Since then we have prepared the various substituted derivatives 
of N-tertiary amino-methly-acid-amides and now we should like to review our syntehtic observa-
tions gained on this field. 
In the N-tertiary amino-methyl-acid-amid group we could observe that the effect exerted on 
the central nervous system is mainly due to the structure. 
From the N-tertiary amino acid amides, first of all, we prepared derivatives substituted by 
various halogens on phenyl radicals, and they showed significant differences in action intensity 
dipending on the position of the halogen substituent. 
Besides the various halogen substituted derivatives we prepared benzoxy- and nitro-compounds 
too. 
Among the acid amides the para-halophenyl derivatives showed the most intensive antinico-
tinic activity. 
In our earlier works [1—5] we had given a detailed review on the synthesis 
and pharmacological investigation [2] regarding the different N-tertiary acetic 
acid (1) and propionic acid-esters [5]. 
Eliminating the ester structure we examined the antinicotinic activity of the 
different ethers, thioethers and sulphones [4], as well as the similar effect of N-ter-
tiary aminopropene and propane-derivatives [5]. 
After preparing and investigating the basic substance (N-piperidino-methyl-
benzamide), we presumed that this compoundgroup conceals the synthesis of seve-
ral substances with intense effect on the central nervous system (C. N. S.) [6]. 
Among the aromatic acid amides some localanestetics and drugs acting on 
the C. N. S. like xylocain, (1) (7) and Nialamide (Niamide) (II) (8) (Chas. Pfizer 
and Co., Inc.) had been detected previously to our findings. 
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yCH3 C 2 H 5 
^ NH.CO.CH2.N < 1 
CH3 C2H5 
(I.) 
N H - N H . c n 2 , C H ; - C O . NH • C H 2 - C 
(II.) 
Therefore it was not surprising to detect a valuable sedative group in the acid 
amides. 
In order to study this group more thoroughly we have carried out a series 
of synthetic investigations. 
To obtain informations on the effect on the C. N. S. we used the examination 
of the antinicotinic activity [3]. 
Before discussing the studies on our synthetic work we should like to deal 
with the MANNICH-typed condensation of aromatic acid amides [9], our aromatic 
acid amide derivatives having been prepared by this method. 
The general formulas of our acidic amides are to be seen below. 
At the syntheses first we usually prepared the substituted benzoic acids, from 
these the adequate acid amides and with the obtained acid amides by M A N N I C H 
condensation the N-terciary-amoni-methyl-acidic amides. 
G 
Among our acid amides, but above all among the N-tertiary-amino-methyl 
acidic amides many unkown compounds could be detected [10]. 
' In the following we should like to concern ourselves with the MANNIEH-typed 
condensation of acid amides. The first investigation with acid amides were carried 
out by E I N H O R N , and in his first publication on this subject he described a number 
of aminomethylated products of acid amides. He illustrated the proceeding reac-
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tion by the folloxing equation: 
O 
II 
R 2 - R ^ - N H + C H 2 0 + H 2 N — C - R 
o 
II 
R 2 R , - N . C H 2 - N H - G - R 
Later LIEBERMAN and W A G N E R [ 1 2 ] as well as H E L M A N N and O P I T Z [ 9 ] had 
been studying the mechanism of the M A N N I C H reaction [ 1 3 ] , and they claimed 
that formaldehyde reacted first with resulting secundery amine components and 
oximethylamine losing water when propionated, and then transformed to a me-
zomer carbenium-imonium-ion. 
This transformation was expected to be the primary agent of the M A N N I C H 
reaction, forming a nucleophyl reaction with an electrophyl condensating partner. 
R ^ N H + C H A O - R ^ N C I ^ O H + H < + > 
The carbenium — imonium ions formed in this way, are acting however in acidic 
medium only, and this N-oximethylamine was formed again in watery medium 
at pH 7. 
In the case of piperidine the following carbenium-imonium iones are formed: 
R i ( - ) ( + ) 
• C H 2 
r / / 
+H2o. 
This ion-form will then react with the substituted acid amides, 
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and the N-piperidino-methyl-acid amides will be forming. Whereas the menti-
oned mechanism explains the phenomenon of the Mannich condensation, the 
reaction in alcalic medium cannot be so clearly elucidated. 
As already mentioned, the halogen substituted tertiary amino methyl-acid 
amides possess an intense antinicotinic activity (6), while the p-hydroxy-substi-
tution leads to a new central spasmodic effect, and this may account for the 5—10-
times stronger efficacity in the case of p-oxy-benzamido-methyl-piperidine-HCl 
compared with Metrazol (14). 
With our later investigations we tried to throw light on the relation of effect 
and structure in the case of o-, p-, m-, oxy-benzamides. 
The nitro substituent eliminated both effects of the above structures. Finally 
we should like to mention the possibility of rearrangement, which may take 
place parallel to the Mannich condensation of different oxibenzamides, but 
above all of the o-oxy-benzamides and possibly may account for the rather con-
trasting pharmacological effect of the oxy-benzamide-derivatives. When reacting 
o-oxybenzamides to Mannich condensation in acidic medium we could equally 
gain the expected o-oxy-benz-amido-methyl-piperidine and the o-oxy-2-benzamido-
4-methyl-piperidine, and this latter structure may be rearranged to substituted 
di-oxy-diphenyl-metharie upon the effect of heat (15). The effect divergent from 
pharmacological effect of the halogen-derivatives arising from the substitution of 
'oxy may point to this phenomenon. The investigation of this problem is in progress. 
Experimental 
As mentioned before, it was E I N H O R N (11) who first studied the Mannich con-
densation of the acid amides. The essential point of his method is that acid amides 
are reacted in methanol or ethanol with aqueous formaldehyde and piperidine. 
O / 
-C.NH2 + CH 2 O+NH.R X R 2 
o 
. C . N H . C H j . N . R i . R j 
Fundamentally we applied the some method too, but in some cases it has been 
modified, as described later. 
Further we shall discuss the preparation of substituted acid amides as well. 
As a rule acid chloride was prepared from substituted acid and it was aminated 
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N-piperidino methylbenzamide was prepared from benzamide with E I N H O R N [ 1 1 ] 
method. 
p-bromtoluene was prepered from p-toluidine with cuprobromide and sulp-
huric acid [16], while p-brombezoic acid was prepared from p-bromtoluene by oxi-
dation with aqueous K M n 0 4 [17]. 
p-brombenzoilchloride was prepared from p-brombenzoic acid with SOCl2 [18,19]. 
p-brombenzamide, on the other hand, was prepared from p-brom-benzoil-
chloride in abs. ether at constant cooling introducing NH3-gas. 
N-piperidinomethyl-p-brombenzamide may be prepared from p-brom-benzamide 
with M A N N I C H condensation. The exact way of preparation will be discussed later. 
The various o-, m-, p-halo-benzamides can be prepared through similar steps from 
adequate toluidimes [16]. 
p-iodotoluene was likewise made from p-toluidine [16], then oxidized with 
K M n 0 4 and thus the proper carbonic acid was gained. 
p-iodobenzoic acidchloride was made from p-iodobenzoic acid with POCl3 
or SOCl2 [19] and acid chloride was converted into acid amide with the aqueous 
solution of NH 4 OH [19]. The halobenzamides won in this way were then carried 
into the M A N N I C H condensation. 
p-tertiary-buthyltoluene was made with the method of BIALOBZENSKI [ 2 0 ] » 
and was transformed into p-tertiary-buthylbenzoic acid by K M n 0 4 oxidation [21]. 
While preparing /?-indolylacetic acid [22] we obtained jS-indolylacetamide as 
by-product. Recrystallizing the P-indolacetic-acid amide we came to the starting 
material used at the M A N N I C H condensation. 
p-nitrobenzoicacidamide was obtained from p-nitrotoluene with aqueous K M n 0 4 
[23]; the starting material was then chlorinated and aminated. 
Nicotinic acidamide was made from nicotinic acidchloride hydrochloride [25] 
with N H 4 0 H solution in aqueous methanol. This was furthered to M A N N I C H con-
densation [26]. 
The preparation of 4-methoxibenzioc acidamide started from 4-methoxibenzoic 
acid and carriedout with the previously mentioned method [27]. 
a-, and P-naphtoic acidamides were prepared from a-and /?-naphtonitril re-
fluxed in ethanol in an alcalic solution [29]. 
Phenylacetic acidamides [30] were prepared from benzyl cyanide. 
3,4-dimethoxyphenylacetic acidamides were made from 3,4-dimethoxy 
phenylacetonitril with alcalic saponification [31]. 
Raceme mandelic acidamide was prepared from mandelic acid heated with 
PC15 and hydrolized with N H 4 O H [32], 
When preparing diphenylacetic acidamide we started out from diphenylacetic 
acid [33] from which diphenylacetic acidchloride [34], further diphenylacetic acid-, 
amide was formed [35]. 
2,4-phenoxiacetic acidchloride was made starting out from 2,4-phenoxiacetic 
acid, then aminating with NH 4 OH. 
The synthesis and the M A N N I C H condensation of this material will be discussed 
later. 
a-and P-naphthaleneacetic acidamide was prepared from a-and /^-naphthalene-
< H N - C H r N H - C - Q k ^ 
Table I. 
x = Summary form M. w . 







C H • N C H N 
H C , , H , 8 O N 2 218,1 1 3 8 - 3 9 181 70,06 8,29 12,83 70,30 8,15 1 2 - 6 3 1 
(o-OH) C , 3 H , 8 0 2 N 2 234 95 171 - 7 2 66,67 7,69 11,69 66,59 7,65 11,90 spasmodic 
o-Cl C 1 3H , 1 7 ON 2 Cl 252,5 186 165 61,80 6,77 11,07 61,93 7,10 11,30 0,5 
p-Cl C 1 3 H 1 7 O N 2 C I 252,5 149,50 177 61,80 6,77 .11,07 62,10 6,80 10,91 0,5 
o-Br C I 3 H i 7 O N 2 B 1 297 200 1 8 0 - 8 1 52,51 5,77 9,42 52,40 5,70 9,63 0,25 
m-Br C13 H i 7 ON 2 Br 297 - 1 7 3 - 7 4 51,52 5,77 9,42 52,63 5,80 9,92 0,5 
p-Br C13 H ,7 ON 2 Br 297 153 184 52,51 5,77 9,42 52,21 5,40 9,45 0,4 
p-J C I 3 H 1 7 O N 2 J 344 148 178 45,04 4,94 8,14 45,1 4,80 8,12 0,4 
p-terc. but. - C 1 7 H 2 6 0 N 2 274,2 160,61 184 73,25 9,56 10,02 73,10 .9,45 10,30 2 







Ö SO c CI 
Table II. 
- R = 
• 
Summary form M. w. 




basis hydro-chloride C H N C H N 
- C H a - 0 - < g ) - C I 
- © - O C H j 
- " V T g t f i ) -
C , 3 H 1 6 0 5 N , 308,1 151,5 202 50,62 5,19 18,18 50,45 9,36 18,26 0,3 
C 1 6 H 2 1 0 N 3 279,16 169 170 70,90 7,77 15,52 71,13 7,91 15,30 0,4 
C14 H20 0 2 N 2 248,16 141 190 . 67,80 8,11 11,29 67,73 8,25 11,43 0,5 
C a o H 2 4 0 N 2 326,16 157 174 73,60 7,39 8,59 73,81 7,24 8,43 0,4 
C m H i S 0 2 N 2 C 1 2 316,94 110 195 53,05 5,72 8,83 52,80 5,93 8,95 . - • 
local ana-
esthetic 
C | 4 H 2 O 0 2 N 2 248,16 137 162 67,80 8,11 11,28 67,50 8,43 10,97 -
C 1 6 H 2 4 O 3N 2 292,16 oil 163 65,80 8,27 9,59 65,40 8,35 9,71 -
C , 8 H 2 6 O N 2 286,2 - 160 75,60 9,16 9,78 75,40 9,12 9,85 1 
C , 8 H 2 2 O N 2 282,17 169 178 76,75 7,83 9,93 76,77 7,99 9,81 0,3 
C , 8 H 2 2 O N 2 282,17 140 1 6 9 - 7 1 76,75 ' 7,83 9,93 76,45 7,91 10,12 1 
C f 7 H 2 0 O N 2 268,16 - .173 76,17 7,47 10,04 76,05 7,53 10,23 0,2 
0 
(HN-~CH2-NH-C-~R 
Table i l l . 
Summary form M. w. 
M. p.° c Caloulated % Found % Rel. antini-
Notes - R = 
basis hydro-
chloride C 
H N C H N 
cotinic 
activity 
C, 7H2OON 2 268,16 173 76,17 7,47 10,04 76,25 7,60 10,12 • - -








CMH20ON2 232,16 118 — 19 185 72,35 8,66 12,02 72,20 8,84 12,21 0 , 2 -
— ( C H ^ — CH 3 C24H480N2 380,38 - 128 75,02 12,57 7,30 75,10 12,63 7,20 0 ,3 -
- Q C , 2 H 1 7 O N 3 219,13 165 66,00 7,92 19,32 66,28 8,11 19,20 
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acetic acid; first we made acidchloride with PC15, then acidamide with concentrated 
NH4OH solution in the case of /?-naphthaleneacetic acidamide [36]; naphthalene 
acetonitril, however, was transformed to acidamide with cc. HC1 at 40° C. 
The 5,6,7,8-tetrahydro-fi-naphthaleneacetic acidamide was made from 5,6,7,8-
tetrahydro-/?-acetonitril with cc. HC1 at 25° C. [38]. 
Terephtalic acidamide was made from terephtalic acid: it was first chlorinated 
at 40° C with PC15 [39], then converted to acidamide with aqueous ammonia [40]. 
Cinnamic acidamide was made from cinnamic acid with N H 3 , then refluxed 
for 3 hours at 150° C [41]. 
Stearic acidamide was prepared by forming stearic acid chloride with PC15. 
from stearic acid [42], then transformed with NH 4 OH into amide [43]. 
In the following we wish to give some typical examples on the M A N N I C H con-
densation made with acidamides, but the physical data and analysis of the basis 
and hydrochlorides are given in table I—III. 
In connection with the condensations first we should like to describe one or 
two typical instances, further we want to speak about the cases in which the con-
densation was not performed with the usual method of the M A N N I C H condensation,' 
either pH of the medium or the applied circumstances being different. 
The next example is a very typical one: 
N-piperidinomethyl-p-brombenzamide. 5,7 gr p-brombenzamide [19] and 2,29 gr 
piperidine was dissolved in 15 ml abs. ethanol and the solution of 2,45 gr 38% 
aqueous formaldehyde. Refluxed for 4 hrs. at 145° C. The hot solution was filtered 
and evaporated in vacuo (5,8 gr). The gained crystallic residue was twice recrys-
tallized from ethanol, HC1 in abs. ethanol M. p.: 153° C. The hydrochloride of 
the basis was prepared, with m. p.: 184° C. (The data of the analysis are shown 
in table I.) 
N-piperidino-methyl-p-iodobenzamide. Warm 6,8 gr. p-iodobenzamide (16) and. 
2,38 gr piperidine was dissolved in 30 ml dioxane, then 3 ml 5% NaOH solution 
and 2,4 gr 38% formaldehyde was added. The mixture was refluxed on water bath 
for 20 minutes, the hot solution filtered and distilled water added until opalescense 
began. For some hours it was left at room temperature and the crystals filtered. 
M. p.: 148° C. 
Hydrochloride was made from the basis gained with abs. etheric HC1. M. p.: 
178° C (Table I.) 
2,4-dichIorophenxoiacetic acidchloride. 40 ml freshly distilled SOCl2 was added 
to 20 gr 2,4-dichorophenoxiacetic acid. The won solution was heated for 2 hours 
on water bath. After cooling, the collected precipitate was filtered, the exess of 
SOCl2 distilled at decreased pressure and the residue fractionately distilled. The 
b. p. of 2,4-dichlorophenoxiacetic acidchloride is 122° C. (2 mm of mercury.)' 
2,4-dichlorophenoxiacetic acidamide. 70 ml cc. N H 3 solution was added to 
2,4-dichlorophenoxiacetic acidchloride at constant stirring and cooling. The formed 
acetic acidamide segregated as a precipitate. The precipitate was filtered, made 
ion-free by washing with distilled water, and the obtained raw product was many 
times recrystallized from ethanol. M. p. 159° C. Calculated: N : 6,3 found: N : 6,25. 
N-piperidionomethyl-2,4-dichlorophenoxiacetic acidamide. On heating 1,95 gr 
piperidine 5 gr. 2,4-dichlorophenoxiacetic acidamide was dissolved in 40 ml abs." 
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-ethanol and 1,9 gr 38% formaldehyde added to the warm solution, then refluxed 
for 10 hrs on water bath, filtered and kept in an ice box for 24 hrs. The crystals 
were filtered out. M. p.: 110°C. (Table II.) The bases dissolved in abs. ethanol 
and the hydrochloride was obtained when treated with the calculated amount of 
HC1 in abs. ethanol. M. p.: 195° C. (Table II). 
N,N'-dipiperidinomethylterphtalic acidamide. The mixture of 5 gr terephtalic 
acidamide (40), 5,2 gr piperidine, 5 gr 38% formaldehyde and 30 ml abs. ethanol 
was refluxed on water bath for 3 hours. The solution was filtered, then the solvent 
•distilled at decreased pressure. A viscous substance remained, which was then 
transformed into hydrochloride in abs. etheric hydrochloric acid, isolated, recrystal-
lized from acetone. M. p.: 270° C. (Table II). 
£ * * 
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ИЗУЧЕНИЕ ДЕЙСТВИЯ М Е Ж Д У ФИЗИОЛОГИЧЕСКИМИ И Х И М И Ч Е С К И М И 
СТРОЕНИЯМИ ВЕЩЕСТВ, ДЕЙСТВУЮЩИХ НА ЦЕНТРАЛЬНЫЙ 
Н Е Р В Н Ы Й МОЗГ 
III. СИНТЕЗ Т Е Р Ц И Е Р А М И Н О В Ы Х - А Ц И Л А М И Д О В 
Ш. Фельдеак, Б. Маткович и И. Порсас 
После синтетических и фармакологических изучений терциераминеэфиров, тио-
эфиров, насыщенных и ненасыщенных аминопропенов, были синтезированы различные-
замещенные производные терциераминовых-ациламидоз. И в настоящих исследованиях. 
наблюдалось, что действие на центральный нервный мозг, в большом размере, зависит 
от строения. Из терциераминевых-ациламидов были сделаны, главный образом, на 
фенилной группе, различные, замещенные производные галогеном. Зависимости о г 
положения галогена, изученные вощества показывали большую разницу в интевснв-
ности. Кроме того были сделаны бенаокси- и нитро-соединения. Из ациламидов Р -
галофениловые производные показывали самое интевсивное антиникотиновое действие. 
